Literature DB >> 22186603

Failed induction of labor: strategies to improve the success rates.

Vikram S Talaulikar1, Sabaratnam Arulkumaran.   

Abstract

UNLABELLED: The rates of induction of labor (IOL) are rising all over the world. In developed countries, one of every 4 babies is born after IOL at term. The recent World Health Organization guidelines on IOL recommend that failure of induction does not necessitate cesarean delivery [WHO recommendations for induction of labor. World Health Organization, 2011]. These guidelines come when there are concerns that failed primary inductions in nulliparous women, which have led to escalation of the cesarean delivery rates. Obstetricians must recognize the risks associated with IOL (including failure and need for cesarean delivery) and avoid inductions for borderline indications, which are not evidence based. The issue of "failed induction of labor" is topical, and there is a need to define this entity and offer alternatives to cesarean delivery in the management of this group of women. Research is required to develop a test to accurately identify those fetuses most at risk of morbidity or stillbirth who would truly benefit from an early IOL and assess the cost-effectiveness of policies of routine IOL. In this review, we summarized the current recommendations for best practice in the area of IOL, defined "failed induction," and described options to improve the success rate after "failed primary induction of labor." TARGET AUDIENCE: Obstetricians & Gynecologists and Family Physicians. LEARNING
OBJECTIVES: After the completing the CME activity, physicians should be better able to classify the factors determining success or failure of induction of labor, counsel women about risks and benefits of various methods of induction of labor, and compare the options of management available after failed primary induction of labor.

Entities:  

Mesh:

Year:  2011        PMID: 22186603     DOI: 10.1097/OGX.0b013e31823e0c69

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  7 in total

1.  Misrecognition of need: women's experiences of and explanations for undergoing cesarean delivery.

Authors:  Kristin P Tully; Helen L Ball
Journal:  Soc Sci Med       Date:  2013-03-05       Impact factor: 4.634

2.  Induction of Labor in Post-Term Nulliparous and Parous Women - Potential Advantages of Misoprostol over Dinoprostone.

Authors:  P Tsikouras; Z Koukouli; B Manav; M Soilemetzidis; A Liberis; R Csorba; G Trypsianis; G Galazios
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-07       Impact factor: 2.915

Review 3.  The Renaissance of Transcervical Balloon Catheters for Cervical Ripening and Labour Induction.

Authors:  W Rath; S Kehl
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-11       Impact factor: 2.915

4.  The Effect of Fetal Gender on the Delivery Outcome in Primigravidae Women with Induced Labours for all Indications.

Authors:  Angeliki Antonakou; Dimitrios Papoutsis
Journal:  J Clin Diagn Res       Date:  2016-12-01

5.  Factors and outcomes associated with the induction of labor in referral hospitals of Amhara regional state, Ethiopia: a multicenter study.

Authors:  Tibeb Zena Debele; Endeshaw Admassu Cherkos; Marta Berta Badi; Kiber Temesgen Anteneh; Fitsum Wolde Demssie; Abdella Amano Abdo; Muhabaw Shumye Mihret
Journal:  BMC Pregnancy Childbirth       Date:  2021-03-20       Impact factor: 3.007

6.  Failed induction of labor and associated factors among women undergoing induction at University of Gondar Specialized Hospital, Northwest Ethiopia.

Authors:  Tsion Tadesse; Nega Assefa; Hirbo Shore Roba; Yohannes Baye
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-03       Impact factor: 3.007

7.  The Uterocervical Angle Combined with Bishop Score as a Predictor for Successful Induction of Labor in Term Vaginal Delivery.

Authors:  Seung-Woo Yang; Seo-Yeon Kim; Han-Sung Hwang; Hee-Sun Kim; In-Sook Sohn; Han-Sung Kwon
Journal:  J Clin Med       Date:  2021-05-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.